Dr. Qadan is a board-certified surgeon and board-certified surgical oncologist practicing in the Division of Surgical Oncology at the Massachusetts General Hospital. Dr. Qadan specializes in complex general surgical oncology with a specialized focus in liver, biliary, and pancreatic cancer surgery.
- Centers & Specialties
- Clinical Interests
- Pancreatic and hepatobiliary surgery
- Liver metastases
- Pancreatic cystic tumors
- Hepatocellular carcinoma, Cholangiocarcinoma, Liver tumors
- Liver surgery
- Pancreatic cancer
- Liver cancer
- Pancreatobiliary surgery
- Surgical oncology
- Minimally invasive surgery
- Robotic surgery
- Medical Education
- MD, University of Edinburgh
- PhD, University of Louisville
- Residency, Stanford University Medical Center
- Fellowship, Memorial Sloan Kettering Cancer Center
- Board Certifications
- Complex General Surgical Oncology
- Boston: Massachusetts General Hospital
- Existing Patients
- Patient Gateway
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - New Hampshire
- OSW - Rhode Island
- Private Health Care Systems (PHCS)
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
- Provider Gender
Motaz Qadan, MD, PhD is a surgical oncologist at the Massachusetts General Hospital. He received his undergraduate and medical degrees from the University of Edinburgh Medical School, which is among the top medical schools in Western Europe.
He completed surgical residency at Stanford University, where he served as administrative chief resident. Following this, he completed a fellowship in complex general surgical oncology at the Memorial Sloan Kettering Cancer Center in New York and served as the educational coordinator during his fellowship.
Dr. Qadan is also a Fellow of the American College of Surgeons (FACS) and a Member of the Royal College of Surgeons of Edinburgh (MRCSEd). He is a surgical member of the multidisciplinary cancer team at the Massachusetts General Hospital in Boston. His practice predominantly includes pancreatic and liver surgery operations.
Patient information and videos can be found at www.vidscrip.com/drmotazqadan
Videos of his most commonly performed operations are also included below.
Whipple (pancreaticoduodenectomy) procedure: https://app.vidscrip.com/vidscrip/5c05bad6ec16aa0007a0d702?fullscreen=1
Distal (subtotal) pancreatectomy procedure: https://app.vidscrip.com/vidscrip/5c05c8f3ec16aa0007a0d8f1?fullscreen=1
Liver resection procedure: https://app.vidscrip.com/vidscrip/5c05c8f3ec16aa0007a0d8f1?fullscreen=1"
- Research Summary
Dr. Qadan completed a doctoral (PhD) degree in the study of immunologic mechanisms that are important in the development of infection following surgery. Dr. Qadan’s research focuses on the tumor microenvironment in the treatment of pancreas cancer. Pancreas cancer is a highly resilient tumor and by influencing the environment and character of the tumor, early data suggests that the disease may be rendered more susceptible to treatments including chemotherapy, radiation, and immunotherapy. He is currently involved in studying novel agents in this field.
In addition, Dr. Qadan is interested in clinical outcomes health services research that focuses on methods to collect, analyze, and improve outcomes related to cancer surgery at the National level. He conducts his outcomes research in collaboration with the Codman Center for Clinical Effectiveness in Surgery.
Finally, Dr. Qadan is an active investigator in high impact clinical trials at the Massachusetts General Hospital in the field of hepatobiliary and pancreatic surgery.
Dr. Qadan is actively involved in many National societies including the AHPBA, SSO, SSAT, American Liver Foundation, and several others. He currently holds active leadership roles in several organizations and has over 60 peer-reviewed scientific articles in high impact surgical journals, as well as several book chapters and scientific abstracts.
55 Fruit Street
Boston, MA 02114-2696